Application 050724
- Type
- NDA
- Sponsor
- LEADIANT BIOSCI INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ABELCET | AMPHOTERICIN B | INJECTABLE, LIPID COMPLEX;INJECTION | 5MG/ML | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050724-001 | ABELCET | AMPHOTERICIN B | 5MG/ML | INJECTABLE, LIPID COMPLEX / INJECTION | RLD | 1995-11-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N050724-001 | ABELCET | 5MG/ML | INJECTABLE, LIPID COMPLEX / INJECTION | RLD | 1995-11-20 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amphotericin B | AMPHOTERICIN B | Sun Pharmaceutical Industries, Inc. | 02aadef1-390b-4270-b56d-33452eb89dde | 2026-04-20 | Warnings, Adverse reactions | AMPHOTERICIN B |
| Amphotericin B | AMPHOTERICIN B | Sun Pharmaceutical Industries, Inc. | 593cffa0-c305-48b6-8ec7-331e0ff91d2b | 2026-04-20 | Warnings, Adverse reactions | AMPHOTERICIN B |
| Amphotericin B | AMPHOTERICIN B | Eugia US LLC | 6f24975c-5191-4fc2-a8da-e57358f8e154 | 2025-06-12 | Warnings, Adverse reactions | AMPHOTERICIN B |
| Amphotericin B | AMPHOTERICIN B | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2b2f3ff5-9d62-4ad2-8eac-1181e5911513 | 2025-06-03 | Warnings, Adverse reactions | AMPHOTERICIN B |
| Amphotericin B | AMPHOTERICIN B | XGen Pharmaceuticals DJB, Inc. | a0a54943-9ce4-4f3e-b681-a1a9144c16ce | 2022-01-03 | Boxed warning, Warnings, Adverse reactions | AMPHOTERICIN B |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 57665-101 | ABELCET | amphotericin b, dimyristoylphosphatidylcholine, dl- and dimyristoylphosphatidylglycerol, dl- | Leadiant Biosciences, Inc. | NDA | Current |
| 57665-101 | ABELCET | amphotericin b, dimyristoylphosphatidylcholine, dl- and dimyristoylphosphatidylglycerol, dl- | Leadiant Biosciences, Inc. | NDA | Current |
| 57665-101 | ABELCET | amphotericin b, dimyristoylphosphatidylcholine, dl- and dimyristoylphosphatidylglycerol, dl- | Leadiant Biosciences, Inc. | NDA | Current |
| 57665-101 | ABELCET | amphotericin b, dimyristoylphosphatidylcholine, dl- and dimyristoylphosphatidylglycerol, dl- | Leadiant Biosciences, Inc. | NDA | Current |
| 57665-101 | ABELCET | amphotericin b, dimyristoylphosphatidylcholine, dl- and dimyristoylphosphatidylglycerol, dl- | Leadiant Biosciences, Inc. | NDA | Current |
| 57665-101 | ABELCET | amphotericin b, dimyristoylphosphatidylcholine, dl- and dimyristoylphosphatidylglycerol, dl- | Leadiant Biosciences, Inc. | NDA | Current |